CA
VERA icon

Cliff Asness’s Vera Therapeutics VERA Stock Holding History

Cliff Asness’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$694K Buy
16,173
+165
+1% +$6.15K ﹤0.01% 3216
2026
Q1 		$644K Buy
16,008
+8,102
+102% +$349K ﹤0.01% 2999
2025
Q4 		$400K Buy
+7,906
New +$281K ﹤0.01% 3030
2025
Q1 		– Sell
-7,736
Closed -$327K – 3201
2024
Q4 		$327K Buy
7,736
+1,054
+16% +$46.7K ﹤0.01% 2460
2024
Q3 		$295K Sell
6,682
-3,000
-31% -$114K ﹤0.01% 2403
2024
Q2 		$350K Sell
9,682
-10,753
-53% -$427K ﹤0.01% 2203
2024
Q1 		$881K Buy
+20,435
New +$728K ﹤0.01% 1751

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cliff Asness's VERA Position: Q2 2026 in Review

Cliff Asness increased its Vera Therapeutics (VERA) stake by 1% in Q2 2026, buying an estimated $6.15K and bringing the position to 16,173 shares worth $694K. The position accounts for ﹤0.01% of the portfolio, ranked #3216.

Cliff Asness first reported a position in VERA in Q1 2024 and has held it in 7 quarters since. The position peaked at $881K in Q1 2024. 218 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Cliff Asness held 16,173 shares of Vera Therapeutics worth $694K as of Q2 2026.
  • Cliff Asness bought 165 Vera Therapeutics shares in Q2 2026, an estimated $6.15K.
  • Vera Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3216 holding.
  • Cliff Asness first reported a position in Vera Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • Cliff Asness's Vera Therapeutics position peaked at $881K in Q1 2024.
  • 218 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.